Detall de la convocatòria


Objectiu de la convocatòria
Bayer's mission is to provide new treatment options for diseases with high unmet medical need.
Bayer HealthCare’s R&D focuses on identifying and developing new active substances for treating diseases with high unmet medical need.
Característiques principals
Grants4Leads® initiative looks for novel small-molecule leads that relate particularly to the fields of oncology, cardiology, hematology and gynecological therapies.
Successful applications would be initially allocated a €5,000 grant, while Bayer assesses the lead’s bioactivity. If confirmed, Bayer might initiate a joint lead-exploration project with the researcher, in which case the researcher would receive further substantial financial support from Bayer HealthCare. Such a collaboration would then be subject to the negotiation of a contract reflecting the interests of all parties involved.
The decision as to whether Bayer offers a grant and/ or enter into a collaboration will be made at the sole discretion of Bayer HealthCare. Please note, that information submitted is non-confidential.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: [email protected] Ext.: 1576
Carol Barnwell: [email protected] Ext.: 1670
Convocatòria (URL)
Researchers from universities, other academic research institutes and start-up companies from all over the world are eligible.
Grant applications can only be submitted via the electronic submission tool: